Arbiter Partners Capital Management — RNA

How Arbiter Partners Capital Management's position in Atrium Therapeutics Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarters held

2

First reported

Q1 2026

Latest value

$3,514,324

Latest weight

2%

Peak weight

2.1%

Shares since first

+13.6%

Position Trend

Shares, value, and weight from first report to latest report.

Arbiter Partners Capital Management first reported 230,000 shares in Q1 2026 and most recently reported 261,288 shares in Q2 2026. Portfolio weight peaked at 2.1% in Q1 2026; the low reported weight was 2% in Q2 2026.

Since the first report, shares are +13.6% and reported value is +14.3%. Latest move: ADD